The US FDA has approved Sanofi’s Sklice (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Sklice Lotion, according to Sanofi, treats lice in most patients with a single 10-minute application of the lotion, without nit combing. “The approval of Sklice Lotion provides physicians and parents with a new treatment option for head lice, a condition that is notoriously frustrating to treat,” said Kenneth P. Guito, general manager, ...